𝔖 Bobbio Scriptorium
✦   LIBER   ✦

1.205 Longitudinal neuropsychometric assessment in patients with Parkinson's disease Dementia: Effect of rivastigmine

✍ Scribed by J. Kassubek; A. Wierciochin; C.A.F. von Arnim

Book ID
117752719
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
57 KB
Volume
13
Category
Article
ISSN
1353-8020

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Effect of rivastigmine on tremor in pati
Effect of rivastigmine on tremor in patients with Parkinson's disease and dementia
✍ Tanya Y. Gurevich; Herzel Shabtai; Amos D. Korczyn; Ely S. Simon; Nir Giladi πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 56 KB πŸ‘ 1 views

## Abstract The purpose of this study was to assess whether rivastigmine, a cholinergic agent, affects tremor features when given to improve cognition in demented Parkinson's disease (PD) patients. Demented PD patients (n = 26; Mini‐Mental State Examination score, 13–25; age, 75.2 Β± 4.9 yr) were gi

Effects of rivastigmine in patients with
Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease
✍ David Burn; Murat Emre; Ian McKeith; Peter Paul De Deyn; Dag Aarsland; Chuanchie πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 190 KB πŸ‘ 1 views

## Abstract We aimed to determine prospectively whether rivastigmine, an inhibitor of acetylcholinesterase and butyrylcholinesterase, provided benefits in patients with and without visual hallucinations in a population with dementia associated with Parkinson's disease (PDD). This was a 24‐week doub